Centene Corporation: Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Centene Corporation is a leading healthcare enterprise providing managed care services primarily through government-sponsored programs (Medicaid, Medicare) and commercial markets. As of March 31, 2025, the company reported total managed care membership of 27.9 million, a decrease of 479,000 members (2%) year-over-year, driven largely by Medicaid redeterminations following the public health emergency.
Key Financial Metrics
| Metric ($ in millions, except per share) | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenues | $46,620 | $40,407 |
| Premium & Service Revenues | $42,489 | $36,337 |
| Net Earnings (GAAP) | $1,311 | $1,163 |
| Adjusted Net Earnings (Non-GAAP) | $1,445 | $1,217 |
| Diluted EPS (GAAP) | $2.63 | $2.16 |
| Adjusted Diluted EPS | $2.90 | $2.26 |
| Operating Cash Flow | $1,510 | $(456) |
| Cash & Equivalents | $14,815 | $17,585 |
| Total Debt | $18,320 | $18,533 |
| Health Benefits Ratio (HBR) | 87.5% | 87.1% |
| SG&A Expense Ratio | 7.9% | 8.9% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 15% year-over-year, driven by a 48% revenue increase in the Medicare segment (primarily PDP growth due to Inflation Reduction Act changes) and a 31% increase in the Commercial segment (Marketplace expansion).
- Profitability: Net earnings rose 13% to $1.31 billion. Adjusted EPS increased 28% to $2.90, reflecting improved operational leverage and the absence of significant divestiture-related expenses seen in Q1 2024.
- Cost Management: The SG&A expense ratio improved to 7.9% from 8.9%, aided by leveraging expenses over higher revenues. However, the Health Benefits Ratio (HBR) increased slightly to 87.5% due to higher Medicaid costs from influenza-like illnesses and post-redetermination acuity.
- Cash Flow: Operating cash flow turned positive at $1.5 billion, a significant improvement from a $456 million outflow in Q1 2024, driven by net earnings and changes in medical claims liabilities.
- Membership: Total membership declined 2% due to Medicaid redeterminations, though Medicare PDP membership grew 22% and Marketplace membership grew 29%.
Outlook, Risks, and Management Commentary
- Regulatory Environment: The Inflation Reduction Act (IRA) significantly impacts 2025 Medicare Part D costs, shifting responsibility to plans and increasing premiums. The enhanced advance premium tax credits for the Marketplace are set to expire at the end of 2025.
- Medicaid Redeterminations: The company anticipates that the majority of states have substantially completed the unwinding of public health emergency protections, with remaining membership reductions expected to be limited.
- Contract Awards: Centene secured several new contracts in 2024 and 2025, including expansions in Florida (Sunshine Health), Kansas, Michigan, and Texas. However, the company is currently protesting Medicaid procurement awards in Georgia and Texas, which could impact future results if unsuccessful.
- Liquidity: The company maintains a strong liquidity position with $14.8 billion in cash and equivalents and $3.25 billion available under its Revolving Credit Facility. The debt-to-capital ratio decreased to 39.5%.
- Risks: Key risks include the potential impact of U.S. government tariffs on healthcare costs, changes in federal or state funding for government programs, and the outcome of ongoing legal and regulatory proceedings.
Investor Verification Checklist
- Medicaid Acuity vs. Rates: Verify the timeline for state partners to adjust Medicaid rates to match the higher acuity of members remaining after redeterminations.
- Medicare Part D Margins: Monitor the quarterly progression of the Medicare segment HBR as the IRA cost-sharing changes fully materialize throughout 2025.
- Contract Protests: Track the resolution of procurement protests in Georgia and Texas, as losing these could materially affect future revenue growth.
- Marketplace Expiration: Assess the potential impact on membership and revenue if the enhanced advance premium tax credits are not extended beyond 2025.
- Dividend Flow: Confirm the receipt of expected net dividends from insurance subsidiaries ($2.2 billion projected for the remainder of 2025) to support capital allocation.